495 related articles for article (PubMed ID: 20497701)
61. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.
Sydorova M; Lee MS
Ophthalmic Res; 2005; 37(4):188-90. PubMed ID: 15990461
[TBL] [Abstract][Full Text] [Related]
62. Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion.
Ki-I Y; Arimura N; Noda Y; Yamakiri K; Doi N; Hashiguchi T; Maruyama I; Shimura M; Sakamoto T
Curr Eye Res; 2007 Dec; 32(12):1065-72. PubMed ID: 18085471
[TBL] [Abstract][Full Text] [Related]
63. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
[TBL] [Abstract][Full Text] [Related]
64. Angiopoietin concentrations in diabetic retinopathy.
Patel JI; Hykin PG; Gregor ZJ; Boulton M; Cree IA
Br J Ophthalmol; 2005 Apr; 89(4):480-3. PubMed ID: 15774928
[TBL] [Abstract][Full Text] [Related]
65. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
[TBL] [Abstract][Full Text] [Related]
66. Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.
Al Kahtani E; Xu Z; Al Rashaed S; Wu L; Mahale A; Tian J; Abboud EB; Ghazi NG; Kozak I; Gupta V; Arevalo JF; Duh EJ
Eye (Lond); 2017 Apr; 31(4):529-536. PubMed ID: 27886182
[TBL] [Abstract][Full Text] [Related]
67. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
[TBL] [Abstract][Full Text] [Related]
68. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy.
Shimura M; Yasuda K; Nakazawa T; Abe T; Shiono T; Iida T; Sakamoto T; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1617-24. PubMed ID: 19639332
[TBL] [Abstract][Full Text] [Related]
69. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Kezuka T; Takeuchi M; Goto H; Iwasaki T
Retina; 2010 Feb; 30(2):339-44. PubMed ID: 20142713
[TBL] [Abstract][Full Text] [Related]
70. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.
Sato T; Kusaka S; Shimojo H; Fujikado T
Ophthalmology; 2009 Sep; 116(9):1599-603. PubMed ID: 19371954
[TBL] [Abstract][Full Text] [Related]
71. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
72. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
[TBL] [Abstract][Full Text] [Related]
73. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
74. Increased sCD200 Levels in Vitreous of Patients With Proliferative Diabetic Retinopathy and Its Correlation With VEGF and Proinflammatory Cytokines.
Xu Y; Cheng Q; Yang B; Yu S; Xu F; Lu L; Liang X
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6565-72. PubMed ID: 26457542
[TBL] [Abstract][Full Text] [Related]
75. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.
Schoenberger SD; Kim SJ; Sheng J; Rezaei KA; Lalezary M; Cherney E
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5906-11. PubMed ID: 22871833
[TBL] [Abstract][Full Text] [Related]
76. Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.
Dai Y; Wu Z; Wang F; Zhang Z; Yu M
Biomed Res Int; 2014; 2014():486386. PubMed ID: 25401103
[TBL] [Abstract][Full Text] [Related]
77. Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy.
Praidou A; Klangas I; Papakonstantinou E; Androudi S; Georgiadis N; Karakiulakis G; Dimitrakos S
Curr Eye Res; 2009 Feb; 34(2):152-61. PubMed ID: 19219687
[TBL] [Abstract][Full Text] [Related]
78. Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.
Gao X; Ma K; Lu N; Xu Y; Hong T; Peng X
Mol Vis; 2015; 21():665-72. PubMed ID: 26120271
[TBL] [Abstract][Full Text] [Related]
79. MicroRNA-200b Expression in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy.
Gomaa AR; Elsayed ET; Moftah RF
Ophthalmic Res; 2017; 58(3):168-175. PubMed ID: 28571008
[TBL] [Abstract][Full Text] [Related]
80. Intravitreous high expression level of netrin-1 in patients with proliferative diabetic retinopathy.
Liu J; Xia X; Xiong S; Le Y; Xu H
Eye Sci; 2011 Jun; 26(2):85-90, 120. PubMed ID: 21692205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
